Generated August 26, 2026 at 8:32 PM ET
· Covers August 26 trading day
· 10 of 148 ready 8-Ks selected
· AI-assisted overview
The day's filings featured several major M&A transactions, including Victory Capital's $7.0B acquisition of First Eagle, Somnigroup's completion of its $2.3B all-stock deal for Leggett & Platt, and AMETEK's $5.0B all-cash purchase of Indicor Instrumentation. In regulatory news, Revolution Medicines received FDA approval for RASONQUE, while CaliberCos and Atlantic American disclosed Nasdaq compliance issues. CuriosityStream announced a CFO transition and raised guidance, and Boston Scientific reported a cybersecurity incident. Additionally, Copper Property Trust filed a fraud lawsuit, and Synergy CHC faced acceleration of its term loan obligations.
CURI
CuriosityStream Inc.
leadership
positive
materiality 0.75
August 26, 2026, 4:09 PM ET
CuriosityStream names Sean Piche CFO; Q2 revenue up 22% to $23.2M, raises FY guidance
- Brady Hayden steps down as CFO effective Sept 1, 2026; no disagreement cited.
- Sean Piche, CPA, appointed CFO effective Sept 1, 2026; 30 yrs media finance experience.
- Piche gets $120K base for 2026, $180K from 2027, 150K RSUs vesting over 4 years.
regulatory
negative
materiality 0.75
August 26, 2026, 5:27 PM ET
CaliberCos gets Nasdaq bid-price deficiency notice; 180-day cure window through Feb 2027
- Nasdaq staff notified CaliberCos on Aug 21, 2026 that bid price closed below $1.00 for 33 consecutive business days.
- Company has 180-day grace period through Feb 17, 2027 to regain compliance with Nasdaq Rule 5550(a)(2).
- To cure, Class A common stock must close at or above $1.00 for at least 10 consecutive business days.
RVMD
Revolution Medicines, Inc.
regulatory
positive
materiality 1.00
August 26, 2026, 1:33 PM ET
FDA approves Revolution Medicines' RASONQUE for metastatic pancreatic adenocarcinoma
- FDA approved RASONQUE (daraxonrasib) on Aug 26, 2026 for adult patients with metastatic pancreatic adenocarcinoma after prior systemic therapy or ineligible for multiagent therapy.
- Approval based on RASolute 302, a global randomized Phase 3 trial vs investigator's choice of cytotoxic chemotherapy in previously treated patients.
- Once-daily oral RASONQUE tablets now available in the U.S. for eligible patients; wholesale acquisition cost $39,800 for 30-day supply.
VCTR
Victory Capital Holdings, Inc.
M&A
positive
materiality 0.90
August 26, 2026, 4:30 PM ET
Victory Capital to acquire First Eagle for ~$7.0B, creating $571B AUM manager
- Total consideration ~$7.0B: $4.4B cash, $2.0B stock, plus assume $575M of First Eagle's 7.25% notes due 2032.
- Combined AUM ~$571B; First Eagle has $222B AUM with positive net flows each of last 3 years.
- Deal expected ~35% accretive to 2027E adjusted EPS; ~$280M net expense synergies; pro forma revenue ~$3.2B.
SGI
SOMNIGROUP INTERNATIONAL INC.
M&A
positive
materiality 0.90
August 26, 2026, 12:41 PM ET
Somnigroup completes $2.3B all-stock acquisition of Leggett & Platt
- All-stock deal valued ~$2.3B; LEG shareholders received 0.1455 SGI shares per share.
- Annual run-rate synergy target raised to $75M from $50M; net leverage ~2.8x at close.
- $1.5B Leggett & Platt senior notes remain outstanding; ~$50M annualized non-cash expense from fair value step-up.
M&A
positive
materiality 0.80
August 26, 2026, 4:42 PM ET
AMETEK completes $5.0B all-cash acquisition of Indicor Instrumentation
- Deal valued at $5.0 billion, all-cash, closed August 26, 2026.
- Indicor Instrumentation expected to add ~$350M to 2026 sales.
- Acquisition expected to be modestly accretive to 2026 adjusted earnings.
AAME
ATLANTIC AMERICAN CORP
regulatory
negative
materiality 0.75
August 26, 2026, 5:03 PM ET
Atlantic American receives Nasdaq notice over delinquent filings; risk of delisting if not filed by Oct 12
- Nasdaq notice Aug 20, 2026 cites failure to file 10-K (2025), 10-Qs (Q1 and Q2 2026) under Listing Rule 5250(c)(1).
- Company has until Sept 4, 2026 to submit updated compliance plan for the Form 10-Q.
- Nasdaq previously granted extension to Oct 12, 2026 to regain compliance; any new extension limited to same date.
CPPTL
Copper Property CTL Pass Through Trust
litigation
negative
materiality 0.75
August 26, 2026, 3:44 PM ET
Copper Property Trust sues Melchionda and Onyx for fraud over failed $947M sale
- Filed complaint Aug 25, 2026 in Suffolk Superior Court (docket 2684CV02549-BLS1) vs Anton Melchionda and Onyx Partners for fraud, tortious interference.
- Alleges defendants misrepresented funding to win June 16, 2025 PSA for 119 retail properties valued at ~$947.0M; deal terminated Dec 2025 after missed closing.
- Defendants filed 30+ lis pendens in 4 states clouding title; trust claims damages over $150M from interference and a stalled liquidation.
BSX
BOSTON SCIENTIFIC CORP
cyber
negative
materiality 0.75
August 26, 2026, 6:06 AM ET
Boston Scientific discloses cybersecurity incident disrupting global operations
- Cybersecurity incident identified Aug 25, 2026 affecting certain IT systems; global operations disrupted.
- Incident limits ability to process and ship customer orders; full restoration timeline not yet known.
- Investigation ongoing with third-party cybersecurity experts; scope, nature, and financial impact not yet known.
debt
negative
materiality 0.90
August 26, 2026, 8:00 AM ET
Synergy CHC receives notice accelerating $18.9M term loan obligations
- ACP Agency, LLC issued Acceleration Notice on Aug 25, 2026 under Term Loan Credit Agreement dated May 30, 2025.
- All commitments under the Credit Agreement terminated; outstanding obligations declared immediately due and payable.
- As of Aug 21, 2026, approximately $18.9M due, exclusive of accruing interest, fees, and costs.